Ono Pharmaceutical Co., Ltd. (TYO:4528)
Japan
· Delayed Price · Currency is JPY 1,558.00
+33.50 (2.20%)
Feb 21, 2025, 3:30 PM JST
Ono Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | 109,782 | 163,734 | 143,532 | 105,025 | 100,890 | 79,696 | Upgrade
|
| Depreciation & Amortization | 22,877 | 18,140 | 17,451 | 17,721 | 15,820 | 14,214 | Upgrade
|
| Loss (Gain) From Sale of Assets | 14,885 | 14,885 | 1,498 | 3,404 | 2,307 | 2,816 | Upgrade
|
| Other Operating Activities | -66,538 | -57,338 | -6,655 | -34,284 | -34,057 | -28,356 | Upgrade
|
| Change in Accounts Receivable | 5,601 | -19,782 | -14,513 | -15,283 | -7,179 | -793 | Upgrade
|
| Change in Inventory | 9,444 | -3,420 | -2,945 | -2,464 | -6,107 | -173 | Upgrade
|
| Change in Accounts Payable | -4,471 | -5,734 | 18,654 | 8,177 | 6,361 | 1,992 | Upgrade
|
| Change in Other Net Operating Assets | 2,982 | 175 | 2,588 | -20,467 | -4,058 | 4,761 | Upgrade
|
| Operating Cash Flow | 92,625 | 110,660 | 159,610 | 61,829 | 73,977 | 74,157 | Upgrade
|
| Operating Cash Flow Growth | -12.65% | -30.67% | 158.15% | -16.42% | -0.24% | 11.06% | Upgrade
|
| Capital Expenditures | -4,760 | -4,020 | -5,340 | -5,497 | -7,018 | -7,475 | Upgrade
|
| Sale of Property, Plant & Equipment | 38 | 903 | 6 | 14 | 2 | 424 | Upgrade
|
| Sale (Purchase) of Intangibles | -12,176 | -16,809 | -9,157 | -6,780 | -13,275 | -14,970 | Upgrade
|
| Investment in Securities | 259,357 | 69,290 | -84,731 | 19,969 | -36,866 | 11,439 | Upgrade
|
| Other Investing Activities | -1,050 | -1,287 | -1,037 | -1,668 | -429 | 348 | Upgrade
|
| Investing Cash Flow | -123,407 | 48,077 | -100,259 | 6,038 | -57,586 | -10,234 | Upgrade
|
| Total Debt Issued | 150,000 | - | - | - | - | - | Upgrade
|
| Total Debt Repaid | -7,921 | - | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 142,079 | - | - | - | - | - | Upgrade
|
| Repurchase of Common Stock | -12,760 | -50,010 | -1 | -30,007 | -3 | -29,584 | Upgrade
|
| Dividends Paid | -37,555 | -37,183 | -29,742 | -27,666 | -22,449 | -22,775 | Upgrade
|
| Other Financing Activities | -2,657 | -2,655 | -2,741 | -2,564 | -2,302 | -2,362 | Upgrade
|
| Financing Cash Flow | 89,107 | -89,848 | -32,484 | -60,237 | -24,754 | -54,721 | Upgrade
|
| Foreign Exchange Rate Adjustments | 411 | 1,116 | 155 | 436 | 403 | -179 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -2 | - | 1 | 1 | - | - | Upgrade
|
| Net Cash Flow | 58,734 | 70,005 | 27,023 | 8,067 | -7,960 | 9,023 | Upgrade
|
| Free Cash Flow | 87,865 | 106,640 | 154,270 | 56,332 | 66,959 | 66,682 | Upgrade
|
| Free Cash Flow Growth | -13.33% | -30.87% | 173.86% | -15.87% | 0.42% | 49.94% | Upgrade
|
| Free Cash Flow Margin | 18.03% | 21.21% | 34.50% | 15.59% | 21.65% | 22.80% | Upgrade
|
| Free Cash Flow Per Share | 187.06 | 222.15 | 315.90 | 113.45 | 134.13 | 132.29 | Upgrade
|
| Cash Interest Paid | 870 | 92 | 74 | 70 | 73 | 76 | Upgrade
|
| Cash Income Tax Paid | 44,093 | 56,431 | 6,637 | 34,293 | 34,060 | 28,357 | Upgrade
|
| Levered Free Cash Flow | 51,590 | 79,783 | 116,639 | 18,091 | 31,716 | 25,044 | Upgrade
|
| Unlevered Free Cash Flow | 53,169 | 79,861 | 116,694 | 18,143 | 31,782 | 25,109 | Upgrade
|
| Change in Net Working Capital | 7,690 | 17,634 | -19,962 | 56,560 | 25,447 | 15,228 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.